Pioglitazone induces regression and stabilization of coronary atherosclerotic plaques in patients with impaired glucose tolerance
Diabetic Medicine,  Clinical Article

Yang HB et al. – Pioglitazone may induce regression and stabilization of coronary atherosclerotic plaques. The mechanisms might involve inhibition of inflammation, increase in adiponectin level and improvement in endothelial function.

  • Thirty patients were randomly divided into two groups: a pioglitazone group and a control group.
  • The latter was administered placebo in addition to standard therapy; the former pioglitazone 15mg/d in addition to standard therapy.
  • Before treatment and 6months later, left ventricular ejection fraction, serum lipid profile, high–sensitivity C–reactive protein, adiponectin and plasma endothelin–1 levels were detected.
  • Coronary plaque area and plaque burden were examined using intravascular ultrasound.

  • No significant differences were found in left ventricular ejection fraction and serum lipid levels pre– and post–trial.
  • Compared with the control group, 6months' treatment with pioglitazone significantly decreased coronary plaque burden (50.7±11.1 vs. 64.1±10.3%, P<0.05), plaque area (6.22±2.03 vs. 8.31±4.29, P<0.05), thin–cap fibroatheroma prevalence (11 vs. 22%, P<0.05) and percentage of necrotic core area (16±8 vs. 31±7%, P<0.05).
  • Compared with the control group, serum high–sensitivity C–reactive protein and plasma endothelin–1 levels were significantly lower and adiponectin level significantly higher in patients in the pioglitazone group.
  • Serum adiponectin level was negatively correlated with plasma endothelin–1 level and coronary plaque area (r=0.739 and –0.431, respectively, both P<0.05).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Internal Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Internal Medicine Articles

Indexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicinemore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More